TNFSF10 and neoplasm: As shown in the Figure S7, cell viability of PC-3 tumor cells pre-treated with 20 μM of Apo-S-Ac3ManNAz was higher than that of non-treated PC-3 tumor cells after 7 ng/ml of TRAIL treatment.